Delivery Order SPE2DR25D1022-SPE2DR26FQT8P
Award Date 1/8/26
Potential Completion Date 1/30/26
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $40,224.30 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6ml units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 2, 2026. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,562.45 on December 11, 2025, for CABENUVA ER 600 MG-900 MG suspension (6 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude by January 5, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG Suspension 6ML on November 7, 2025, with completion targeted for December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply arrangement with DLA. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,921.10 for CABENUVA ER 600 mg-900 mg suspension (6 mL) on January 2, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical...
- This is a $22,820.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the pharmaceutical product CABENUVA ER 600 MG-900 MG SUSP 6ML. It has an ultimate completion date of December 11, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly military and veterans' healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL) with a ceiling value of $40,224.30 and a firm fixed price contract type. This delivery order is non-set-aside and will be completed by January 14, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $45,802.80 firm fixed-price delivery order contract is for the provision of CABENUVA ER 600 MG-900 MG SUSP 6ML, a medical product. The contract has an ultimate completion date of February 5, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of CABENUVA ER (cabotegravir/rilpivirine) 600 mg-900 mg suspension in 6 mL vials, valued at $38,169.00. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract has an ultimate completion date of October 3, 2025, and will be performed at the awardee's location in...
- This delivery order, valued at $40,921.10 and awarded on January 8, 2026, is for CABENUVA ER 600 MG-900 MG suspension (6 mL) supplied by AmerisourceBergen Drug Corp to the Defense Logistics Agency. The award utilizes a firm fixed-price structure with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the awardee operating as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...